ClinVar Miner

Submissions for variant NM_000278.5(PAX2):c.166C>T (p.Arg56Trp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Hainan Provincial Key Laboratory for Human Reproductive Medicine and Genetic Research RCV004596592 SCV004232725 likely pathogenic Focal segmental glomerulosclerosis 7 no assertion criteria provided clinical testing We collected retrospective clinical data of the proband and conducted whole exome sequencing (WES) to identify the causative gene. Subsequently, Sanger sequencing was employed to validate the mutation detected by WES in additional family members. The proband (Ⅲ-1) exhibited fetal renal hypodysplasia. WES revealed a novel heterozygous missense variant (c.166C>T, p.Arg56Trp) within the PAX2 gene in the proband, inherited paternally. This mutation affected highly conserved residues and was predicted to disrupt the normal protein structure. Furthermore, the variant co-segregated with the disease phenotypes within the family. The variant was classified as 'likely pathogenic (PM2 + PM5 + PP1 + PP3)' based on the latest ACMG guidelines on sequence variants. The diagnosis of FSGS7 was established, with the identified variant considered causative.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.